Document is current
Any future updates will be listed below
-
Authors
Grissom, Colin K. http://orcid.org/0000-0001-9477-272X
Holubkov, Richard
Carpenter, Lori
Hanna, Bridgett
Jacobs, Jason R.
Jones, Christopher
Knighton, Andrew J.
Leither, Lindsay
Lisonbee, Dee
Peltan, Ithan D.
Winberg, Carrie
Wolfe, Doug
Srivastava, Rajendu
-
Funding
Funding for this research was provided by:
National Institutes of Health (U01HL159878)
- License Information
-
More Information
Article History
Received: 27 July 2023
Accepted: 9 September 2023
First Online: 21 September 2023
Declarations
:
: Study protocol is approved by the Intermountain Health Institutional Review Board with waiver of informed consent on July 28, 2022 (no. 1051681).
: N/A.
: IDP reports grants from the National Institutes of Health, Centers for Disease Control and Prevention, and Janssen Pharmaceuticals and funding to his institution from Regeneron and Asahi Kasei Pharma. RS reports grants from the National Institutes of Health, the Agency for Healthcare Research, the Centers for Disease Control and Prevention, and the Patient-Centered Research Outcomes Institute. RS is also a physician founder of the IPASS Patient Safety Institute, and his equity is owned by his employer, Intermountain Health. RH reports grants from the National Institutes of Health and consulting (DSMB member) for Pfizer. CKG report grants from the National Institutes of Health. Other authors declare that they have no competing interests.
